Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03104959 · ClinicalTrials.gov registry record · NA
Use of NAC in Prevention of Hangover Symptoms; Independent Alcohol Consumption Protocol
A NA study, sponsored by St. Luke's Hospital and Health Network, Pennsylvania.
- Terminated
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT03104959 is a NA study that was terminated before completion, run by St. Luke's Hospital and Health Network, Pennsylvania. The registered enrollment target is 200 participants.
The verdict
NCT03104959, a NA study, was terminated before completion, sponsored by St. Luke's Hospital and Health Network, Pennsylvania.
- TERMINATED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
This is a double-blinded study involving healthy non-alcoholic (self-reported) volunteers over the age of 21. Consent is obtained prior to participation in the study while the participant is sober. Volunteers are recruited from residency programs, hospital employees, emergency medical personnel, and friends of the study investigators. If the volunteers choose to drink, they can participate in the study the night of ingestion of alcohol. There is no amount we ask them to drink, and we allow them to withdraw from the study at any time. We never force them to drink alcohol, or even encourage it. The participation is completely voluntary, if they would like to participate and if they choose to drink alcohol, we ask them to participate in the placebo controlled study in the safety of their own home. Then materials for the study are given out prior to their participation. An envelope is given with the questionnaire, and a small packet containing 3 pills of either NAC or placebo, and a small smear of Vicks vapor rub concealed in a small packet. At the end of their alcohol ingestion, the volunteer is asked to estimate the number roof drinks consumed and take 1 capsule per 3 drinks consumed of either 600 mg N-Acetyl-L-Cysteine or placebo capsules. In the morning, each participant fills out a Hangover Symptom Score questionnaire . A random number generator is used to determine placebo or NAC first, then the participant is given the other treatment at their subsequent encounter. Then study is being conducted over a series of many months, and data can be analyzed by the hangover symptoms scale data when using NAC compared to placebo. The data will be analyzed using the numerical values of each category for hangover classification and compare the placebo data to the control data.
Interventions
- OTHER placebo
- DIETARY_SUPPLEMENT N-acetyl cysteine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2016-01 |
| Est. Completion | 2018-06-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03104959
The ClinicalTrials.gov registry entry for NCT03104959 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Luke's Hospital and Health Network, Pennsylvania, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT03104959 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03104959 about?
NCT03104959 is a clinical study titled "Use of NAC in Prevention of Hangover Symptoms; Independent Alcohol Consumption Protocol". This is a double-blinded study involving healthy non-alcoholic (self-reported) volunteers over the age of 21. Consent is obtained prior to participation in the study while the participant is sober. Volunteers are recruited from residency programs, hospital employees, emergency medical personnel, and...
What is the current status of trial NCT03104959?
This trial is currently terminated. It is a NA study. The enrollment target is 200 participants. The study started on 2016-01. Estimated completion is 2018-06-06.
What interventions are being tested in trial NCT03104959?
The interventions under investigation include: placebo (OTHER), N-acetyl cysteine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03104959?
This trial is sponsored by St. Luke's Hospital and Health Network, Pennsylvania, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.